These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15682512)

  • 1. Cancer vaccines: pessimism in check.
    Timmerman JM; Levy R
    Nat Med; 2004 Dec; 10(12):1279; author reply 1279-80. PubMed ID: 15682512
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer vaccines: pessimism in check.
    Mocellin S; Mandruzzato S; Bronte V; Marincola FM
    Nat Med; 2004 Dec; 10(12):1278-9; author reply 1279-80. PubMed ID: 15580242
    [No Abstract]   [Full Text] [Related]  

  • 3. The roles of heat shock proteins in tumor immunity.
    Li Z
    Cancer Chemother Biol Response Modif; 2001; 19():371-83. PubMed ID: 11686024
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
    Croix BS
    Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer immunotherapy: moving beyond current vaccines.
    Rosenberg SA; Yang JC; Restifo NP
    Nat Med; 2004 Sep; 10(9):909-15. PubMed ID: 15340416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New frontiers in cell-based immunotherapy of cancer.
    D'Elios MM; Del Prete G; Amedei A
    Expert Opin Ther Pat; 2009 May; 19(5):623-41. PubMed ID: 19441938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer vaccines: toward the next revolution in cancer therapy.
    Emens LA
    Int Rev Immunol; 2006; 25(5-6):259-68. PubMed ID: 17169776
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapy for cancer: focusing on developing treatments rather than drugs.
    Sznol M
    Curr Opin Investig Drugs; 2001 Jul; 2(7):957-8. PubMed ID: 11757798
    [No Abstract]   [Full Text] [Related]  

  • 9. The capacity of the immune system to control cancer.
    Håkansson L
    Eur J Cancer; 2009 Aug; 45(12):2068-70. PubMed ID: 19608409
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer immunotherapy: new approaches].
    Blay JY; Thomachot MC; Alberti L; Bachelot T; Voorzanger-Rousselot N; Puisieux I; Odin L; Ménétrier-Caux C
    Bull Cancer; 2000 Jan; 87(1):97-106. PubMed ID: 10673638
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancer immunotherapy targeting WT1 product which overexpressess in various kinds of malignant neoplasms].
    Oka Y; Tsuboi A; Sugiyama H
    Tanpakushitsu Kakusan Koso; 2003 Aug; 48(11 Suppl):1663-70. PubMed ID: 12931627
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting cancer therapy.
    Begent RH
    Br J Cancer; 1999 Jul; 80 Suppl 1():104-9. PubMed ID: 10466768
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccines to treat cancer--an old approach whose time has arrived.
    Hellstrom KE; Hellstrom I
    J Cell Biochem; 2007 Oct; 102(2):291-300. PubMed ID: 17729239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer vaccines.
    Kiessling R; Choudhury A
    Br J Surg; 2007 Dec; 94(12):1449-50. PubMed ID: 18022792
    [No Abstract]   [Full Text] [Related]  

  • 16. Improving the efficacy of cancer immunotherapy.
    Copier J; Dalgleish AG; Britten CM; Finke LH; Gaudernack G; Gnjatic S; Kallen K; Kiessling R; Schuessler-Lenz M; Singh H; Talmadge J; Zwierzina H; Håkansson L
    Eur J Cancer; 2009 May; 45(8):1424-31. PubMed ID: 19167214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 18. Developing enabling technologies for the success of cancer immunotherapy.
    Sznol M
    Curr Opin Investig Drugs; 2004 Dec; 5(12):1239-42. PubMed ID: 15648943
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic cancer vaccines.
    Ward S; Dalgleish A
    Vaccine; 2007 Sep; 25 Suppl 2():B1-3. PubMed ID: 17681649
    [No Abstract]   [Full Text] [Related]  

  • 20. MUC1 as a target antigen for cancer immunotherapy.
    Acres B; Limacher JM
    Expert Rev Vaccines; 2005 Aug; 4(4):493-502. PubMed ID: 16117706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.